(1999; 168 pages) [Spanish]
11.2 Training programmes for the detection of counterfeit pharmaceutical products
The Committee approved provisional guidelines for developing training programmes of inspection and examination for counterfeit pharmaceuticals (Annex 9). It recognized that a competent regulatory staff is essential for the detection and prevention of counterfeit, spurious and substandard pharmaceuticals. Education and training programmes for the detection of counterfeit pharmaceutical products must be designed and implemented efficiently and effectively within the countries' quality assurance programmes for pharmaceuticals.